Holen Sie sich die Stockscreener-App
0.4014
0.15%
-0.0006
Handel nachbörslich:
.40
-0.0014
-0.35%
Schlusskurs vom Vortag:
$0.402
Offen:
$0.4
24-Stunden-Volumen:
154.72K
Relative Volume:
0.06
Marktkapitalisierung:
$16.45M
Einnahmen:
$653.40K
Nettoeinkommen (Verlust:
$-20.19M
KGV:
-0.2219
EPS:
-1.8091
Netto-Cashflow:
$-11.11M
1W Leistung:
+2.92%
1M Leistung:
-2.15%
6M Leistung:
-32.18%
1J Leistung:
-54.20%
1-Tages-Spanne:
$0.3923
$0.4084
1-Wochen-Bereich:
$0.3795
$0.419
52-Wochen-Spanne:
$0.2382
$2.60
Scienture Holdings Inc Stock (SCNX) Company Profile
Firmenname
Scienture Holdings Inc
Sektor
Branche
Telefon
(800) 261 0281
Adresse
20 AUSTIN BLVD., COMMACK
Compare SCNX vs WGRX, HITI, PETS, POM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.4049 | 16.33M | 653.40K | -20.19M | -11.11M | -1.8091 |
WGRX
Wellgistics Health Inc
|
3.845 | 10.39M | 23.34M | -101.27M | -11.74M | -1.2919 |
HITI
High Tide Inc
|
2.36 | 210.08M | 452.61M | -35.30M | 13.25M | -0.3863 |
PETS
Petmed Express Inc
|
2.23 | 45.37M | 182.67M | -64.87M | -22.92M | -3.1193 |
POM
Pomdoctor Ltd Adr
|
0.1111 | 16.48M | 0 | 0 | 0 | 0.00 |
Scienture Holdings Inc Aktie (SCNX) Neueste Nachrichten
Scienture Holdings Reports 449% Revenue Growth and 95.6% Gross Margin Expansion in Q1 2026, Driven by Arbli and REZENOPY Launches - Minichart
Scienture Holdings Inc. (SCNX) Q1 2026 Earnings: Narrower-than-expected loss drives positive surprise - Newser
Scienture Holdings (SCNX) Faces Selling Pressure Near Key Support LevelViral Trade Signals - Newser
Scienture Holdings Inc. (SCNX) Q1 2026 Earnings: Significant EPS Beat Highlights Cost Discipline and Operational ProgressViral Trade Signals - Newser
Trxade Health announces name change to Scienture Holdings - Intellectia AI
MEDS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - Intellectia AI
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - Intellectia AI
MEDS Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
MEDS News & Events - Intellectia AI
Scienture Holdings (SCNX) Q1 2026 Earnings Surprise: EPS $-0.08, Up SignificantViral Trade Signals - Newser
Scienture Holdings Releases Q1 2026 Financial Results - AlphaStreet
Scienture Holdings, Inc. released its financial results and business progress for the first quarter of 2026. - Bitget
Scienture Holdings Q1 revenue jumps on Arbli sales, operating expenses steady - TradingView
SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion - The Manila Times
SCIENTURE、2026年第1四半期の業績を発表 大幅な収益増と粗利益率拡大が目立つ - Moomoo
Scienture Holdings Secures $11.4 Million Structured Financing Deal - TipRanks
Scienture Holdings (SCNX) Q4 2025 Earnings: EPS $-0.11 Beats EstimatesTrading Community Hub - Newser
Scienture Holdings Inc (FRA:4E4) Stock Price, Trades & News - GuruFocus
Scienture Holdings: Q1 Earnings Snapshot - marketscreener.com
Scienture Holdings Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Scienture Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Number of shareholders of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
TradingKey - TradingKey
Scienture (SCNX) Secures Patent for Innovative Losartan Suspensi - GuruFocus
Scienture secures $11M debt financing for product launches By Investing.com - Investing.com South Africa
Scienture secures $11M debt financing for product launches - Investing.com UK
Scienture secures $11.0 million in non-dilutive debt financing to accelerate growth of approved product portfolio and advancement of research and development pipeline - marketscreener.com
Scienture secures $11 million in non-dilutive debt financing - Investing.com
Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline - The Manila Times
$11M debt funds Scienture's hypertension drug and overdose spray - Stock Titan
Scienture Holdings Secures $11M Debt Financing Via Note Purchase Agreement >SCNX - Moomoo
Scienture Holdings, Inc. Secures $11 Million in Non-Dilutive Debt Financing - marketscreener.com
Scienture Holdings Issues Updated Investor Presentation Disclosure - The Globe and Mail
Scienture receives third patent for liquid losartan product - Investing.com
Scienture receives third patent for liquid losartan product By Investing.com - Investing.com Australia
SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041 - The Manila Times
Scienture secures third patent for ARBLI™ oral suspension, extending market exclusivity to 2041. - Pluang
[8-K] Scienture Holdings, Inc. Reports Material Event - Stock Titan
Scienture Holdings, Inc. Enters $11.42 Million Secured Note Agreement with Streeterville Capital, LLC – April 2026 - Minichart
Scienture Holdings, Inc. 2025 Annual Report: Company Overview, Executive Leadership, and Financial Highlights - Minichart
Scienture Holdings Secures $11.42 Million in Secured Notes Financing From Streeterville Capital - TradingView
Scienture (NASDAQ: SCNX) adds 9% and 5% secured notes with asset pledges - Stock Titan
Deep 2025 loss at Scienture (NASDAQ: SCNX) after $26,346,050 impairments - Stock Titan
MSN Money - MSN
SCNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Scienture granted 180-day extension by Nasdaq to regain compliance - MSN
Finanzdaten der Scienture Holdings Inc-Aktie (SCNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
10.99%
5.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):